KATIE WADE: Open Payments
NPI 1285265421 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 49 payments from 11 companies in 2025. Trend: 2023 $349 · 2024 $678 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 11 | $171 |
| Supernus Pharmaceuticals, Inc. | 8 | $154 |
| Alkermes, Inc. | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 5 | $97 |
| Almatica Pharma LLC | 4 | $79 |
| ABBVIE INC. | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
Products named: Azstarys, Qelbree, LYBALVI, FANAPT, LOREEV XR, VRAYLAR, Jornay PM, INGREZZA.
Industry payments across TN — which companies pay providers there.
